This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Lecithin is fatty substances commonly found in nutritional supplements.
- Generic Name
- Lecithin
- DrugBank Accession Number
- DB15834
- Background
A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Lecithins
- Phosphatidylcholine
- Phospholutein
- External IDs
- LT-02
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image MENAPHASE FORMULA FILM TABLET, 90 ADET Lecithin (18 mg) + Ascorbic acid (42 mg) + Biotin (0.05 mg) + Calcium (167 mg) + Choline (3.1 mg) + Chromium (0.0217 mg) + Copper (0.33 mg) + Cyanocobalamin (0.0083 mg) + Ferrous gluconate (3 mg) + Folic acid (0.067 mg) + Inositol (3.1 mg) + Iodine (0.0025 mg) + Magnesium oxide (84 mg) + Manganese (0.6 mg) + Molybdenum (0.0083 mg) + Niacin (8.3 mg) + Calcium pantothenate (8.3 mg) + Phosphorus (35 mg) + Potassium citrate (8.3 mg) + Pyridoxine (16.7 mg) + Riboflavin (8.5 mg) + Selenium (0.0117 mg) + Thiamine (7.5 mg) + Vitamin A (833 IU) + Vitamin D (67 IU) + Vitamin E (67 IU) + Zinc (2.5 mg) Tablet Oral FERROSAN SAĞLIK ÜRÜN VE HİZMETLERİ A.Ş. 2020-08-14 Not applicable Turkey 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- 8002-43-5
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Acute Liver Injury, Drug Induced 1 4 Unknown Status Treatment Hepatitis B Chronic Infection 1 3 Completed Treatment Hepatic and Hepatobiliary Disorders 1 3 Completed Treatment Ulcerative Colitis 1 3 Recruiting Treatment Acute Liver Injury, Drug Induced 1 3 Recruiting Treatment Fear of open spaces / Generalized Anxiety Disorder / Panic Disorder / Social Anxiety Disorder (SAD) 1 3 Terminated Treatment Ulcerative Colitis 2 3 Withdrawn Treatment Autoimmune Hepatitis 1 2 Active Not Recruiting Treatment Moderate or Severe Submental Fullness 2 2 Completed Treatment Acute Liver Injury, Drug Induced 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, gelatin coated Oral Gel Topical Capsule Oral 1200 mg Capsule, gelatin coated Oral Capsule Oral Capsule Oral 420 mg Capsule, liquid filled Oral Tablet Oral Capsule Oral Capsule Oral 1000 MG - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at September 14, 2020 21:52 / Updated at July 03, 2021 01:49